EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Early specialised treatment for bipolar disorder: Long‐term follow‐up from the early intervention in affective disorders ( EIA ) randomised controlled trial

Klaus Munkholm iD, Lars Vedel Kessing iD

Acta Psychiatrica Scandinavica · 2024

DOI: 10.1111/acps.13716 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Psychiatrica Scandinavica, 2024. Verfasst von Klaus Munkholm und 1 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Affective Disorders Research Center (CADIC), Psychiatric Center Copenhagen, Mental Health Services, Capital Region of Denmark, Copenhagen,…. Hauptthemen laut MEDLINE: Bipolar Disorder. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Independent Research Fund Denmark, Region Hovedstadens Psykiatri, Danmarks Frie Forskningsfond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It is unclear whether treatment early after onset in bipolar disorder may improve the long‐term illness course. The early intervention in affective disorders (EIA) randomised controlled trial found that 2‐years treatment in a specialised mood disorder clinic combining evidence‐based pharmacological treatment with group psychoeducation improved clinical outcomes compared with standard treatment in patients with bipolar disorder discharged after their 1st, 2nd, or 3rd hospital admission. We aimed to assess the 16 years long‐term outcomes after randomisation of the participants in the EIA trial.

Methods

Data were obtained by linking nation‐wide Danish population‐based registers. All 158 participants of the EIA trial (Trial Registration Number NCT00253071) were followed from time of randomisation (2005–2009) to end of study (31 December 2021). The primary outcome was risk of psychiatric readmission. Secondary outcomes were total admissions and costs, medication use, intentional self‐harm or suicide attempt or suicide, and socio‐economic measures.

Results

The absolute mean risk of psychiatric readmission was 49.3% in the intervention group and 59.8% in the control group, with no statistically significant difference between the groups ( b = −0.10, 95% CI: −0.26 to 0.047, p = 0.18). Compared with the control group, patients in the intervention group had numerically fewer total admission days (mean (SD) 44 (77) versus 62 (109)), lower total cost of psychiatric hospital admissions and hospital‐based outpatient visits (mean (SD) 22,001 (36793) euros versus 29,822 (52671) euros) and higher use of lithium and antipsychotics, but the differences were not statistically significant. Fewer patients in the intervention group had an event of intentional self‐harm or suicide attempt or suicide during follow‐up (OR 0.25, 95% CI: 0.15–0.40, p < 0.001) compared with the control group and more patients in the intervention group used antiepileptics (OR 2.21, 95% CI: 1.08–4.60, p = 0.031).

Conclusion

Analyses of very long‐term outcomes of the EIA trial may potentially indicate a beneficial effect of the intervention at the long term but were likely underpowered to detect a more subtle effect and for most outcomes the differences between groups were not statistically significant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderHumansAdultMaleFemaleFollow-Up StudiesDenmarkEarly Medical InterventionMiddle AgedPatient ReadmissionSuicide, AttemptedSelf-Injurious BehaviorOutcome Assessment, Health CarePsychotherapy, GroupHospitalization

Stichwörter der Autor:innen

bipolar disorderearly interventionoutpatient treatmentrandomised trialregister‐based study

Autor:innen und Institutionen

  • Copenhagen Affective Disorders Research Center (CADIC), Psychiatric Center Copenhagen, Mental Health Services, Capital Region of Denmark, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Klaus Munkholm, Lars Vedel Kessing

Förderung

  • Independent Research Fund Denmark
  • Region Hovedstadens Psykiatri
  • Danmarks Frie Forskningsfond

Zitieren

APA

Munkholm, K., & Kessing, L. V. (2024). Early specialised treatment for bipolar disorder: Long‐term follow‐up from the early intervention in affective disorders ( EIA ) randomised controlled trial. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13716

Vancouver

Munkholm K, Kessing LV. Early specialised treatment for bipolar disorder: Long‐term follow‐up from the early intervention in affective disorders ( EIA ) randomised controlled trial. Acta Psychiatrica Scandinavica. 2024. doi:10.1111/acps.13716

BibTeX
@article{Munkholm2024,
  author = {Munkholm, Klaus and Kessing, Lars Vedel},
  title = {Early specialised treatment for bipolar disorder: Long‐term follow‐up from the early intervention in affective disorders ( EIA ) randomised controlled trial},
  journal = {Acta Psychiatrica Scandinavica},
  year = {2024},
  doi = {10.1111/acps.13716}
}
Kostenlos starten →